Orion Metal Exchange Releases The 2025 Silver Guide: The Right Metal at the Right Time

Orion Metal Exchange has just released “The 2025 Silver Guide: The Right Metal at the Right Time,” a commissioned report that explores silver's historic run fueled by its critical supply deficit and rising dual sector demand. The report highlights silver's low cost of entry, mining forecast, high-tech applications, and price projections for 2025. https://mma.prnewswire.com/media/2601123/Orion_2025_Silver_Guide_COVER.jpg Major […]

Industry Leaders, Informativ and ComplyAuto, Partner to Offer AI-powered End-to-End Compliance

Strategic alliance strikes a balance for dealers, enabling comprehensive compliance and faster vehicle sales. Informativ, the leading provider of compliance solutions, credit reporting and customer insights to automotive dealers, lenders, and other end markets, and ComplyAuto, the renowned privacy software platform announced a strategic alliance that will integrate their respective platforms to deliver dealers the

B. Riley Financial Announces Full Redemption of February 2025 Senior Notes

Provides Update on Preferred Stock Dividends B. Riley Financial, Inc. (NASDAQ: RILY) (“B. Riley” or the “Company”), a diversified financial services company, today announced the redemption on February 28, 2025 (the “Redemption Date”) of all the issued and outstanding 6.375% Senior Notes due February 28, 2025 (NASDAQ: RILYM) (the “Notes”). The redemption price for the

Old National Bancorp Reports Fourth Quarter and Full-Year 2024 Results

(NASDAQ:ONB), EVANSVILLE, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) — Old National Bancorp (NASDAQ: ONB) reports 4Q24 net income applicable to common shares of $149.8 million, diluted EPS of $0.47; $156.0 million and $0.49 on an adjusted1 basis, respectively. Full-year net income applicable to common shares of $523.1 million, diluted EPS of $1.68; $578.1 million and

Levine Leichtman Capital Partners and Management Acquire SYNERGY HomeCare

Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced today that it has partnered with management to acquire SYNERGY HomeCare Franchising, LLC (“SYNERGY” or the “Company”) from NexPhase Capital, LP (“NexPhase”). Financial terms of the transaction were not disclosed. https://mma.prnewswire.com/media/2349427/LLCP_Logo.jpg SYNERGY is an industry-leading provider of in-home care services to seniors and

PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

CPRI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Capri Holdings Limited to Contact the Firm Today!

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Capri Holdings Limited ("Capri" or "the Company") (NYSE:CPRI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

ProcessMaker Positioned as the Leader in the 2024 SPARK Matrix™: Intelligent Business Process Management Suites (iBPMS) by QKS Group

— The QKS Group SPARK Matrix™ provides competitive analysis and ranking of the leading iBPMS vendors. — ProcessMaker with its comprehensive technology and customer experience management, has received strong ratings across the parameters of technology excellence and customer impact. QKS Group has named ProcessMaker as a Leader in their 2024 SPARK Matrix™ analysis of the

BioLineRx Issues Letter to Shareholders

Company outlines strategic long-term vision and financial outlook – BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today issued the following letter to shareholders. https://mma.prnewswire.com/media/2154863/BioLineRx_Ltd_Logo.jpg To my fellow shareholders, It has been approximately two months since we announced a major strategy shift with the signing

Southern States Bancshares, Inc. Announces Fourth Quarter 2024 Financial Results

(NASDAQ:SSBK), Fourth Quarter 2024 Performance and Operational Highlights Net income of $11.2 million, or $1.11 per diluted share Core net income(1) of $10.5 million, or $1.04 per diluted share(1) Pretax pre-provision core net income(1) of $14.0 million Net interest income of $25.1 million, an increase of $804,000 from the prior quarter Net interest margin (“NIM”)

Scroll to Top